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Abstract
Individuals with the autosomal recessive skeletal disorder Progressive Pseudorheumatoid Dysplasia have loss-of-
function mutations in WISP3, and aberrant WISP3 expression has been detected in tumors from patients with colon
and breast cancer. In mice however, neither absence nor over-expression of WISP3 was found to cause a
phenotype, and endogenous Wisp3 expression has been difficult to detect. To confirm that Wisp3 knockout mice
have no phenotype and to identify potential sites of endogenous Wisp3 expression, we generated mice with a
knockin allele (Wisp3GFP-Cre) designed to express Green Fluorescent Protein (GFP) and Cre-recombinase instead of
WISP3. Heterozygous and homozygous knockin mice were fertile and indistinguishable from their wild-type
littermates, confirming that mice lacking Wisp3 have no phenotype. We could not detect GFP-expression from the
knockin allele, but we could detect Cre-expression after crossing mice with the knockin allele to Cre-reporter mice;
the double heterozygous offspring had evidence of Cre-mediated recombination in several tissues. The only tissue
that had high levels of Cre-mediated recombination was the testis, where recombination in spermatocytes occurred
by early prophase of meiosis I. As a consequence, males that were double heterozygous for a Wisp3GFP-Cre and a
floxed allele only contributed a recombined allele to their offspring. We detected no evidence of Cre-mediated
recombination in the female ovary, although when double heterozygous females contributed the reporter allele to
their offspring it had recombined ~7% of the time. Wisp3GFP-Cre expression therefore occurs less frequently and most
likely at a later stage of oocyte development in female mice compared to male mice. We conclude that although
WISP3 is dispensable in mice, male mice with a Wisp3GFP-Cre allele (Jackson Laboratory stock # 017685) will be
useful for studying early prophase of meiosis I and for efficiently recombining floxed alleles that are passed to
offspring.
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Introduction
Wnt1 inducible signaling pathway protein 3 (WISP3/CCN6) is
a member of the connective tissue growth factor family (CCN)
of proteins [1]. The 6 CCN family members share a common
structure comprised of an N-terminus signal peptide and four
domains bearing homology to insulin-like growth factor binding
protein, von Willebrand factor, thrombospondin 1, and cysteine-
knot containing proteins [2,3]. CCN proteins are key signaling/
regulatory factors involved in a wide variety of cellular
processes including, cell adhesion, extracellular matrix
remodeling, skeletal development, chondrogenesis,
angiogenesis, wound repair, cell proliferation and
tumourigenesis (reviewed in 1,4). Such a diversity of
interactions is facilitated by the modular architecture of CCN
proteins, whereby the 4 domains can either act individually or
in multiple combinations to confer specificity [5].
WISP3 was first identified by DNA sequence homology and
subsequently found to have altered expression levels in colon
cancers [3]. Further studies showed that somatic WISP3
frameshift mutations occur frequently in mismatch repair
deficient colorectal carcinomas [6,7] and WISP3 expression is
frequently reduced or lost in inflammatory breast cancers [8,9].
Inherited loss-of-function mutations in WISP3 cause the
autosomal recessive, skeletal disorder Progressive
Pseudorheumatoid Dysplasia (PPD) [10–13].
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Investigations into the in vivo role of WISP3 in PPD and,
more generally, in cartilage formation/maintenance have met
with little success [14,15]. Although morpholino-mediated
knockdown of Wisp3 expression in zebrafish produces a
craniofacial cartilage phenotype [16], neither over-expression
[15] nor mutation of Wisp3 [14] produced any discernable
phenotype in mice. Wisp3 and WISP3 mRNAs were detected
by RT-PCR in several mouse [14] and human [3] tissues,
respectively, but not by in situ hybridization.
Immunohistochemistry has been unable to detect endogenous
WISP3 protein.
To elucidate the expression pattern of Wisp3 in mice, we
generated knockin mice in which a Green Fluorescent Protein
(GFP) - internal ribosomal entry site - Cre recombinase (Cre)
expression cassette was inserted in-frame into the first exon of
Wisp3, three amino acids downstream of the endogenous
Wisp3 translation initiation codon. This knockin allele,
Wisp3GFP-Cre, was designed to express GFP and Cre in place of
WISP3. Here we describe the expression pattern of the
Wisp3GFP-Cre allele.
Materials and Methods
All animal work was performed as approved by the
Institutional Animal Care and Use Committee at Boston
Children’s Hospital.
Construction of the GFP-Cre Targeting Vector and
generation of Wisp3GFP-Cre knockin mice
The following DNA elements were PCR amplified,
subcloned, and ligated to produce a GFP-IRES-Cre-Neo
targeting vector (Figure 1).
1 FRT-PGK-EM7-Neo-FRT selection cassette from pL451 [17]
2 5’ and 3’ Wisp3 targeting arms from BAC RP24_541B4
(CHORI, Oakland, CA)
3 eGFP, IRES, and Cre from pIGCN21 [18]
4 Thymidine kinase selection cassette from pL253 [17]
The full-length targeting vector was linearized and used to
perform homologous recombination in V6.5 (C57BL/6 x 129S4/
SvJae)F1 ES cells using positive (G418) and negative
(Ganciclovir) selection. Correct targeting of ES cells was
confirmed by long-range PCR (P1 aacgccagtgctcaactccatctcac
and P2 tgctcaggtagtggttgtcg for 5’ targeting and P3
gggaggattgggaagacaat and P4 ccatgaaggaagccctatga for 3’
targeting), and one correctly targeted ES cell clone was
introduced into C57BL6/J blastocysts to produce chimeric and
then germline- transmitted Wisp3+/GFP-Cre-Neo mice with a mixed
genetic background. The FRT-flanked Neo selection cassette
was removed by crossing a Wisp3+/ GFP-Cre-Neo mouse with a FLP
deleter mouse (B6.129S4-Gt(ROSA) 26Sortm1(FLP1)Dym/RainJ;
Jackson Laboratory stock # 009086). Offspring with the Neo
allele excised (i.e., Wisp3+/GFP-Cre) were used to generate the
mice used in all subsequent experiments. In-frame insertion of
GFP into the first exon of Wisp3 in mice with Wisp3GFP-Cre
alleles was confirmed by PCR (P5 gtggagacgtggttccttgt and P6
cacactgaagccttcttgca-3’), subcloning, and sequencing.
Genotyping alleles at the Wisp3 and ROSA26 loci
Total DNA was extracted from mouse tail tips using the
HotSHOT method [19]. Genotyping of mice with the
ROSA26mTmG allele ((ROSA) 26Sortm4(ACTB-tdTomato,-EGFP)Luo;
Jackson Laboratory stock # 007576) was performed as
recommended by the Jackson Laboratory for this strain.
Genotyping of the Wisp3GFP-Cre allele was performed with a
three-primer reaction (F cgtaggctcctcttttgcac; R1
gaacttcagggtcagcttgc; and R2 tgcaagaaggcttcagtgtg) designed
to generate a 256 bp amplimer for the wild-type Wisp3 allele
and a 180 bp amplimer for the Wisp3GFP-Cre knockin allele. PCR
conditions were: 94°C for 2 min followed by 30 cycles of 94°C
for 30 sec, 55°C for 30 sec, and 72°C for 45 sec, followed by a
7 minute 68°C polish.
Detecting Cre-recombination of the ROSA26mTmG allele
Total DNA was extracted from individual tissues using the
DNeasy blood and tissue extraction kit (Qiagen). One primer
pair (mT-F gcaacgtgctggttattgtg and mT-R
tgatgacctcctctcccttg) was designed to generate a 200 bp
amplimer from the non-recombined ROSA26mTmG allele and
another primer pair (mG-F gttcggcttctggcgtgt and mG-R
tgctcacggatcctaccttc) was designed to generate a 376 bp
amplimer from the Cre-recombined ROSA26mTmG allele. PCR
conditions for both reactions were: 95°C for 1 min followed by
35 cycles of 94°C for 15 sec, 62°C for 30 sec, and 72°C for 1
min, followed by a 2.5 minute 72°C polish. The sensitivity of the
latter primer pair for detecting Cre-recombination of the
ROSA26mTmG allele was determined by performing PCR using
template genomic DNA from non- recombined mice that
contained serial diluted genomic DNA from mice that had
completely recombined alleles. The unmixed genomic DNAs
were used as negative and positive controls for each primer
pair, and the recombination assay was performed using 200 ng
of template DNA.
Tissue Collection/Preparation
Mice were euthanized immediately prior to tissue collection.
For histologic analyses, dissected tissues were washed thrice
in 1x phosphate buffered saline (PBS) and fixed in 4%
paraformaldehyde (USB) in PBS at 4°C overnight. Tissues
were then washed once with 1x PBS and cryoprotected in 30%
sucrose in PBS at 4°C. Samples were embedded in OCT
(Tissue-Tek) and stored at -80°C. Eight to 10 µm sections were
cut onto glass slides, washed thrice in 1x PBS, and treated with
DAPI staining solution (Molecular Probes) and Fluromount-G
(Southern Biotech).
Fluorescence microscopy was performed on a Nikon Eclipse
80i fitted with Nikon Digital Sight DS-Ri1 and Photometrics
Coolsnap HQ2 cameras (DAPI, FITC, Cy5 and Cy3 filters).
Images were captured using NIS-Elements AR 3.10
software, with channel and capture parameters standardized.
For DNA and RNA extraction, tissues were washed thrice in
1x PBS and placed directly in Allprotect Tissue Reagent
(Qiagen) or RNAlater (Invitrogen) at 4°C for a minimum of 24
hrs. DNA and RNA were extracted using either DNeasy Blood
& Tissue Kit (Qiagen) or Trizol (Invitrogen) following the
manufacturers’ recommendations.
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Figure 1.  Generation of a knockin GFP-CRE allele at the Wisp3 locus.  (Upper panel) Schematic diagram of the Wisp3 locus,
the targeting vector, and the Wisp3lacZΔex3-5 and Wisp3GFP- Cre alleles (not drawn to scale). Exons 1-5 are indicated as rectangles, with
the 5’ untranslated region (UTR) of exon 1 a thinner rectangle. The Wisp3GFP-Cre targeting construct contains a thymidine kinase
cassette (TK) for negative selection, an enhanced Green Fluorescent Protein (GFP) cassette, an internal ribosomal entry site
(IRES), a Cre-recombinase (Cre) cassette, a polyA addition signal (rGpA), and a FRT (diamonds) flanked Neomycin resistance
cassette (NeoR), all inserted into Wisp3 exon 1. DNA sequences from the correctly targeted Wisp3GFP-Cre allele are shown. The two
potential translation initiation codons of endogenous Wisp3 are underlined, as is the translation initiation codon in the GFP
expression cassette. NotI and SalI restriction sites are in italics. FRT sequence 3’ of the NeoR cassette, the remainder of Wisp3
exon 1, and beginning of Wisp3 intron 1 are indicated. Arrows indicate the locations of the PCR primers used to generate the
amplimers shown in the lower panels. The P1 and P4 primers lie outside of the targeting arms (Lower panels). A) PCR amplimers
demonstrating correctly targeted alleles in Wisp3GFP-Cre/GFP-Cre mice and their absence in wild-type mice. B) PCR amplimers
demonstrating insertion of the GFP-IRES-Cre cassette into Wisp3 exon 1 in heterozygous and homozygous knockin mice (arrows
indicate the expected products from the knockin and wild-type alleles). C) PCR amplimers used to genotype wild-type,
heterozygous, and homozygous knockin littermates and the Wisp3 locus in C57BL6/J mice (control). Sizes of the molecular weight
standards (MS Std) in kb or bp are indicated.
doi: 10.1371/journal.pone.0075116.g001
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RT-PCR of Wisp3
Mouse RNA’s were bought from Ambion (AM5730G),
Zyagen (MR-108, MR-109) and BioChain (R4334566). Reverse
transcription was performed using Ready-To-Go You-Prime
First-Strand Beads (GE Healthcare) with 2 µg RNA and
OligoDT(20) primers (Invitrogen).
PCR was performed using Taq-pro Complete (Denville
scientific) with Wisp3 specific, exon/intron spanning, primers
(ExF tgtggcagttggatgtgagt and ExR cccggttagaaattcccatt).
Non- reverse transcribed RNAs from the stocks served as
negative controls for genomic DNA contamination. PCR
conditions were: 94°C for 2 min followed by 35 cycles of 94°C
for 30 sec, 55°C for 30 sec, and 72°C for 45 sec, followed by a
7 minute 68°C polish.
Results and Discussion
Creation of Wisp3GFP-Cre knockin mice
Figure 1 depicts the targeting strategy used to generate the
Wisp3GFP-Cre allele. Mouse Wisp3 has 2 potential translation
initiation codons in exon 1. We used a NotI restriction site to
add three alanine residues between the second translation
initiation codon of Wisp3 and the translation initiation codon of
GFP (Figure 1). Depending upon which of the 3 potential
translation initiation codons was used by the knockin allele, the
GFP protein product would contain 14, 4, or 0 additional amino
acid residues at its amino terminus. We confirmed correct
targeting by long-range PCR (Figure 1) and sequencing (data
not shown), and excised the Neo- cassette with a Flippase
expressing mouse. After confirming the Neo-cassette had been
excised, we intercrossed Wisp3+/GFP-Cre mice and produced
Wisp3+/+, Wisp3+/GFP-Cre, and Wisp3GFP-Cre/GFP-Cre offspring (Figure
1) at the expected Mendelian frequencies. Wisp3+/GFP-Cre and
Wisp3GFP- Cre/GFP-Cre mice were indistinguishable from their wild-
type littermates when followed to >12 months-of-age, and they
were fertile. Seventeen matings between Wisp3GFP-Cre/GFP-Cre
mice produced an average of ~9 pups/litter and a male: female
pup ratio of 1.07.
We previously generated a mutant allele of Wisp3,
Wisp3lacZΔex3-5, by replacing exons 3 -5 with a lacZ reporter and
a Neomycin selection cassette (Figure 1) [14]. This mutant
allele was designed to produce a mutant allele of mouse Wisp3
that was comparable to several homozygous deletion and
nonsense WISP3 mutations that cause Progressive
Pseudorheumatoid Dysplasia in humans [10,12]. These
homozygous Wisp3-mutant mice also appeared normal and
were fertile on two different genetic backgrounds (129SvEv and
C57BL/6) [14]. Thus, the inability of two different Wisp3 loss-of-
function alleles to recapitulate the phenotype of Progressive
Pseudorheumatoid Dysplasia on different genetic backgrounds
argues strongly against WISP3 function in the skeleton being
conserved between humans and mice. We cannot preclude the
possibility that another murine CCN family member is
compensating for WISP3 deficiency. To date, only Wisp1/
Wisp3 double knockout mice have been studied; they are
indistinguishable from Wisp1 knockouts alone (personal
communication from Professor Karen Lyons, UCLA, Los
Angeles, CA).
Comparing sites of endogenous Wisp3 expression to
sites of GFP and Cre expression from the Wisp3GFP-
Creallele
Wisp3 expression is poorly represented in expressed
sequence tags (EST) and RNA sequencing (RNA-seq) data
sets, and has not been reliably detected by in situ hybridization
[14]. Therefore, to determine which mouse tissues express
Wisp3 mRNA, we performed RT-PCR using commercially
available total RNA from multiple mouse tissues. We were able
to amplify spliced Wisp3 RNA from several tissues, including
cartilage, kidney, testis, heart, liver, and brain (Figure 2). To
determine whether the Wisp3GFP-Cre allele expressed GFP in
these tissues, we examined frozen sections from Wisp3GFP-Cre/
GFP-Cre mice by fluorescence microscopy. We were unable to
detect GFP expression from the Wisp3GFP-Cre allele in any tissue
(Figure 3 and data not shown). We next determined whether
Cre was expressed from the Wisp3GFP-Cre allele by crossing
Wisp3+/GFP-Cre mice with ROSA26mTmG/mTmG mice and looking for
evidence of Cre-mediated recombination at the ROSA26 locus
in multiple tissues by PCR and by fluorescence microscopy.
We first determined that our PCR protocol could detect ~ 0.1%
recombination of the ROSA26mTmG allele by mixing genomic
DNA from mice in which the ROSA26mTmG allele was intact or
fully recombined (data not shown). We then used this assay to
identify which tissues in Wisp3+/GFP-Cre; ROSA26+/mTmG double
heterozygous mice had evidence of Cre-mediated
recombination, and found evidence of recombination in testis,
heart, and brain. Because the PCR assay was not quantitative,
we also examined these same tissues for recombination using
fluorescence microscopy; cells with a ROSA26mTmG allele that
had not recombined have membranes that fluoresce red, while
cells with a Cre-recombined ROSA26mTmG allele have
membranes that fluoresce green. Testis was the only tissue in
which fluorescence microscopy revealed Cre-mediated
recombination of the ROSA26mTmG allele (Figure 3 and data not
shown).
Although the Cre activity we observed for the Wisp3GFP-Cre
allele in testis was consistent with the endogenous Wisp3
expression we observed in this tissue by RT-PCR, and other
investigators observed in human testis [3], there was no
correlation between Cre activity and Wisp3 expression in other
tissues. For example, cartilage, liver, and kidney had
detectable Wisp3 expression by RT-PCR but no evidence of
Cre activity in the reporter mice. One explanation for why
Wisp3 expression may have been detected by RT-PCR, while
Cre-mediated recombination was not, is that only a tiny fraction
(< 0.1%) of cells in these tissues express Wisp3 but at very
high levels. These few high-expressing cells could make
transcript detectable by RT-PCR in a total tissue RNA pool, but
since only a very small fraction of cells actually express Cre
from the Wisp3GFP-Cre allele, Cre-mediated recombination
occurred too infrequently to be detected with our recombination
assay. The alternative and more likely explanation is that Cre-
expression from the Wisp3GFP-Cre allele does not truly mirror
endogenous Wisp3 expression. That we could not find cells,
other than spermatocytes and their descendents in the testis,
expressing membrane bound GFP in the Wisp3+/GFP-Cre;
A Cre-Driver Active during Male Meiosis I
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Figure 2.  Endogenous Wisp3 expression and Wisp3GFP-Cre expression are not identical.  (Upper panel) RT-PCR amplimers
indicating the presence of Wisp3 transcript in total RNA from a several different mouse tissues. A schematic of Wisp3 mRNA is
indicated (not drawn to scale) along with the locations of the intron-spanning PCR primers and the expected amplimer size for
correctly splice mRNA (Lower panel). A schematic of the ROSA26mTmG allele before and after Cre-recombination (not drawn to
scale) along with the locations of the PCR primers and the expected amplimer sizes for the non-recombined and recombined
alleles. PCR amplimers indicating non-recombined ROSA26mTmG DNA (upper gel) in all tissues and Cre-mediated recombination
(lower gel arrowheads) in testis, heart, and brain recovered from Wisp3+/GFP- Cre;ROSA26+/mTmG mice (floxed and recombined template
DNA serves as controls for the two primer pairs). Note that there is poor correlation between endogenous Wisp3 expression (upper
panel) and Wisp3GFP-Cre activity (lower panel).
doi: 10.1371/journal.pone.0075116.g002
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ROSA26+/mTmG double heterozygous mice supports this latter
explanation.
The Wisp3GFP-Cre allele is highly efficient at producing
Cre-mediated recombination during early prophase of
male meiosis I
The strong Cre-activity we observed in the testis of Wisp3+/
GFP-Cre mice led us to determine the efficiency of this allele in
producing germline recombination. We bred two Wisp3+/GFP-Cre;
ROSA26+/mTmG males to wild-type females. Of 186 offspring
generated from these crosses, 85 mice inherited the
ROSA26mTmG allele and this allele had recombined in all
(100%). To identify the earliest stage during spermatogenesis
at which Cre activity became detectable, we collected testes
from male Wisp3+/GFP-Cre; ROSA26+/mTmG mice at different
postnatal ages and examined them for evidence of Cre-activity
by PCR and fluorescence microscopy (Figure 4). By
fluorescence microscopy, Cre-recombination of the
ROSA26mTmG allele was apparent in the seminiferous tubules of
15-day-old (P15) mice. Our PCR-based assay was able to
detect evidence of Cre-mediated recombination in testis as
early as P10 (data not shown). This timeframe coincides with
the onset of early prophase of meiosis I during mouse
spermatogenesis [20].
We performed the converse experiment by breeding wild-
type males and three Wisp3+/GFP-Cre; ROSA26+/mTmG females. Of
157 offspring, 72 inherited the ROSA26mTmG allele and this
allele had recombined in 5 of the 72 mice (~7%). All three
females had pups with a recombined allele. Recombination
appears to have occurred during female gametogenesis, since
none of the 5 pups had evidence of somatic mosaicism for the
non-recombined and recombined alleles by PCR (data not
shown). We examined the ovaries of the Wisp3+/GFP-Cre;
ROSA26+/mTmG dams by fluorescence microscopy to look for
evidence of Cre-mediated recombination in oocytes but found
none (data not shown). Most oocytes in fertile female mice are
arrested at the diplotene stage of prophase I [21,22]. Since that
stage of oocyte arrest is later than the stage in meiosis in which
Wisp3+/GFP-Cre-mediated recombination had already occurred in
males, it appears as though Wisp3+/GFP-Cre expression
commences later and less often during female meiosis
compared to male meiosis.
Several transgenic and knockin mice express Cre-
recombinase in male spermatogonia, spermatocytes, and/or
spermatids (reviewed in 23,24). Mice that express Cre-
recombinase during spermatogenesis or oogenesis, and that
are heterozygous for a floxed allele, have great utility in
generating recombined alleles in their progeny. Male Wisp3GFP-
Cre mice, which we have donated to The Jackson Laboratory
(stock # 017685), should be particularly useful for this purpose
since they are healthy, fertile, and highly efficient Cre-deleters
in early spermatocytes. Also, since the Wisp3 GFP-Cre allele is a
knockin, rather than a transgene, its chromosomal location is
known (Chr10:39150971-39163794; in the GRCm38/mm10
Figure 3.  The Wisp3GFP-Cre allele is expressed during spermatogenesis.  Fluorescence microscope images of seminiferous
tubules from adult male mice that are wild-type (Wisp3+/+) or heterozygous knockin (Wisp3+/GFP-Cre) at Wisp3, and wild-type
(ROSA26+/+) or heterozygous knockin (ROSA26+/mTmG) at ROSA26. Cell nuclei are imaged with DAPI dye. Autofluorescence in the
GFP channel is observed in Wisp3+/+;ROSA26+/+ and Wisp3+/GFP-Cre;ROSA26+/+ mice.
Tomato Fluorescent Protein (TFP) is observed in Wisp3+/+;ROSA26+/mTmG mice and in the non- spermatocyte/spermatid cells of
Wisp3+/GFP-Cre;ROSA26+/mTmG mice. Green Fluorescent Protein (GFP) is observed in spermatocytes and spermatids, but not in
spermatogonia, of Wisp3+/GFP- Cre;ROSA26+/mTmG mice.
doi: 10.1371/journal.pone.0075116.g003
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genome assembly) and it is unlikely to be subject to epigenetic
silencing. In addition to transmitting recombined alleles to
progeny, Wisp3GFP-Cre mice can be used to specifically
determine the consequence of altering gene expression in
spermatocytes during meiosis I. The Wisp3GFP-Cre allele
produces minimal Cre-recombinase activity in cells/tissues
other than spermatocytes, and thus Wisp3GFP-Cre mice are
unlikely to have significant off-target effects. This contrasts with
transgenic strains containing Cre-drivers that are active during
male meiosis I, such as Pgk2-Cre [25,26], Hspa2- Cre [27,28],
and Synapsin-Cre [29]. These strains are efficient Cre-deleters
during paternal transmission but they exhibit significant Cre-
activity in multiple tissues during embryogenesis and post-
natally, which can limit their usefulness in studying male
spermatogenesis.
Conclusion
The Wisp3GFP-Cre allele produces extremely efficient Cre-
recombinase activity in male spermatocytes by early prophase
of meiosis I, and minimal recombination in other tissues. Thus,
males with a Wisp3GFP-Cre allele and floxed alleles at other loci
can be used to study the roles of these other loci during male
meiosis I, without causing significant off-target effects.
Importantly, by driving complete recombination in male
gametes, the Wisp3GFP-Cre allele should be very useful for
converting a floxed allele to a recombined allele in offspring.
Wisp3GFP-Cre mice have been donated to the Jackson
Laboratory (stock # 017685).
Three reporters (LacZ, GFP, and CRE) have been knocked
into the Wisp3 locus, and none have mirrored the Wisp3
expression pattern suggested by RT-PCR. Consequently, the
Wisp3GFP-Cre allele may not inform us regarding the endogenous
expression pattern of Wisp3. Furthermore, the lack of a
phenotype in Wisp3GFP-Cre/GFP-Cre mice indicates that the mice do
not recapitulate the phenotype of WISP3 deficiency in humans
and are unlikely to inform us regarding the pathogenesis of
human Progressive Pseudorheumatoid Dyplasia. Despite their
lack of utility in teaching us about PPD, male mice with
Wisp3GFP-Cre alleles are excellent “Cre- deleters” and male and
female mice offer a new means for dissecting spermatogenesis
and oogenesis. As with any genetically modified allele, it is
possible that the Wisp3GFP-Cre allele, alone, could produce a
phenotype depending on the mouse’s genetic background.
Investigators should consider this possibility when using the
Wisp3GFP-Cre allele in their experiments.
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Figure 4.  Wisp3GFP-Cre activity occurs in spermatocytes early during meiosis I.  Fluorescence microscope images of
seminiferous tubules from Wisp3+/GFP-Cre;ROSA26+/mTmG male mice at 5, 10, 14, 15, 17, 19 and 27 days-of-age (P5 – P27). Cell nuclei
are imaged with DAPI dye. Spermatocytes expressing membrane bound Green Fluorescent Protein (GFP) instead of Tomato
Fluorescent Protein (TFP), which indicates that Cre-mediated recombination has occurred, become visible by P15 and increase in
abundance with age. Germ cells and spermatogonial cells, which reside near the periphery of seminiferous tubules, do not express
GFP. The location of the GFP expressing cells in the seminiferous tubules, coupled with PCR evidence of recombination by P10
(data not shown), suggests that the Wisp3GFP-Cre allele is expressed in spermatocytes between the leptotene and pachytene stages
of male meiosis I.
doi: 10.1371/journal.pone.0075116.g004
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